hydroxyurea has been researched along with Arthritis, Degenerative in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Most lesions were osteonecrosis and osteoarthritis and were statistically associated with the non-use of hydroxyurea." | 4.02 | Chronic osteo-articular changes in patients with sickle cell disease. ( de Araújo Pereira, G; Dos Santos, APT; Ferreira, TFA; Leal, AS; Moraes-Souza, H; Silva, SS, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferreira, TFA | 1 |
| Dos Santos, APT | 1 |
| Leal, AS | 1 |
| de Araújo Pereira, G | 1 |
| Silva, SS | 1 |
| Moraes-Souza, H | 1 |
| Cortes-Burgos, LA | 1 |
| Zweifel, BS | 1 |
| Settle, SL | 1 |
| Pufahl, RA | 1 |
| Anderson, GD | 1 |
| Hardy, MM | 1 |
| Weir, DE | 1 |
| Hu, G | 1 |
| Happa, FA | 1 |
| Stewart, Z | 1 |
| Muthian, S | 1 |
| Graneto, MJ | 1 |
| Masferrer, JL | 1 |
2 other studies available for hydroxyurea and Arthritis, Degenerative
| Article | Year |
|---|---|
Chronic osteo-articular changes in patients with sickle cell disease.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Antisickling Agents; Cross-Sectional Studies; Female; Hemogl | 2021 |
CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain.
Topics: Administration, Oral; Animals; Arachidonate 5-Lipoxygenase; Blotting, Western; Cell Line; Disease Mo | 2009 |